Project: A therapeutic vaccine to eradicate pre-malignant HPV16 and HPV18 infection and prevent cancer

Acronym THERIN (Reference Number: 12151)
Duration 03/07/2018
Project Topic The consortium has 3 Goals: Commercial: Deliver proof-of-concept for elimination of pre-existing papillomavirus infection in non-human primates and a human candidate vaccine ready to enter clinical development. Science advance: The first therapeutic HPV vaccine in humans matching prophylactic vaccines in efficacy Social impact: Substantial prevention of virus-induced cancer on a global scale with the potential to lower healthcare expenses
Network Eurostars 2
Call Eurostars Cut-Off 8

Project partner

Number Name Role Country
1 Sirion Biotech GmbH Coordinator Germany
2 InProTher ApS Partner Denmark
3 Københavns Universitet Partner Denmark
4 Universität Regensburg Partner Germany